Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to recruit 30 patients who have been referred to Auerach Hematology
Oncology Assoc. for the treatment of iron defeciency anemia with iv iron (Ferumoxytol 1020
mg) administered via infusion pump over 15 minutes.
To ascertain acute safety and tolerability of ferumoxytol during immediate post dosing
observation period.
Assess additional safety profile and laboratory assessment at follow up visit and interim
telephone follow up.